Target ID and Validation

Target ID and Validation

Begin your drug discovery journey by identifying the function of your small molecule or biotherapeutic target and its role in disease intervention. Through early screening and characterization, you can better understand the molecular mechanism and determine the “druggability” of the target of interest. Whether you’re investigating a novel target or investigating an orphan disease, Eurofins Discovery empowers you through validated tools and technologies to progress your research forward, step by step.
 
Explore our portfolio or consult with a drug discovery specialist to qualify your target for function, mechanism of action, efficacy and safety.

Key Areas

Our technical experts and partner lab can customize in vivo testing for your specific study design or disease model, creating an efficient process that propels you closer to the clinic.

Phenotypic drug discovery gives you a head start on clinical success with translationally relevant biomarkers as functional readouts for insights on mechanism of action, efficacy, and toxicity assessments.

Advance your drug discovery with our unparalleled portfolio of off-the-shelf assays against challenging targets, LeadHunter.

Discover comprehensive protein production services, leveraging bacterial, insect, and mammalian expression systems for high-quality, scalable protein.

Your organization may have a novel target, pathway, or phenotype of interest, or a new approach in a well-explored area—along with challenges in program implementation.

Choosing a custom-tailored solution can provide you with more incisive data, give your pipeline a competitive advantage, and save weeks or even months in your discovery timeline.